Ocular Therapeutix shareholders approve 3.6M share increase under 2021 Stock Incentive Plan

OCULAR THERAPEUTIX, INC

Stockholders approved amendment to 2021 Stock Incentive Plan, increasing authorized shares by 3,600,000.
Elected Seung Suh Hong, Richard L. Lindstrom, and Leslie J. Williams as Class II directors until 2025.
Non-binding advisory vote on executive compensation passed: 31,197,580 for, 10,723,248 against.
Ratified PricewaterhouseCoopers as independent auditor for fiscal 2022 with 60,017,922 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.